ASA-B0765
Warning: Last items in stock!
Availability date:
GAPDH Antibody
Recipient :
* Required fields
or Cancel
Long Name | Antibody Type | Antibody Isotype | Host | Species Reactivity | Validated Applications | Purification |
glyceraldehyde-3-phosphate dehydrogenase | Polyclonal | IgG | Rabbit | Human, Mouse, Rat | IHC-P, WB | Immunogen affinity purified. |
Immunogen | ||||||
A synthetic peptide corresponding to a sequence at the C-terminus of human GAPDH (320-335aa YSNRVVDLMAHMASKE), different from the related mouse and rat sequences by one amino acid. |
Form | Lyophilized |
Size | 100 µg/vial |
Contents | Antibody is lyophilized with 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal and 0.05 mg NaN3. *carrier free antibody available upon request. |
Concentration | Reconstitute with 0.2 mL sterile dH2O (500 µg/ml final concentration). |
Storage | At -20 °C for 12 months, as supplied. Store reconstituted antibody at 2-8 °C for one month. For long-term storage, aliquot and store at -20 °C. Avoid repeated freezing and thawing. |
Gene | GAPDH, GAPDH |
Protein | Glyceraldehyde-3-phosphate dehydrogenase(GAPDH) |
Uniprot ID | P04406 |
Function | Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively. Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis. Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC. Modulates the organization and assembly of the cytoskeleton. Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules (By similarity). Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D- glyceroyl phosphate. Component of the GAIT (gamma interferon- activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma treatment assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation. |
Tissue Specificity | |
Sub-cellular localization | Cytoplasm, cytosol. |
Sequence Similarities | Belongs to the glyceraldehyde-3-phosphate dehydrogenase family. |
Aliases | Aging associated gene 9 protein antibody|G3P_HUMAN antibody|G3PD antibody|G3PDH antibody|GAPD antibody|GAPDH antibody|Glyceraldehyde 3 phosphate dehydrogenase antibody|Glyceraldehyde 3 phosphate dehydrogenase liver antibody|Glyceraldehyde 3 phosphate dehydrogenase muscle antibody|Glyceraldehyde-3-phosphate dehydrogenase antibody|MGC88685 antibody|OCAS p38 component antibody|OCT1 coactivator in S phase 38 KD Component antibody|Peptidyl-cysteine S-nitrosylase GAPDH antibody |
Application | Concentration* | Species | Validated Using** |
Western blot | 0.1-0.5μg/ml | Human, Mouse, Rat | AssaySolutio's ECL kit |
Immunohistochemistry(Paraffin-embedded Section) | 0.5-1μg/ml | Human, Mouse, Rat | AssaySolutio's IHC/ICC Detection kit |